Proteomic Study Suggests Potential Approach for Targeting "Undruggable" Proteins

Dec 20, 2013

|

Premium

Using a combination of proteomic approaches, researchers from Boston's Brigham and Women's Hospital, the Broad Institute, and the Dana-Farber Cancer Institute have identified the mechanism of action of the multiple myeloma drug lenalidomide.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Breaking News

The Scan

This Week in Nature

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Its Own Version

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

Just the Train Going By

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

New Technique a 'Go'

The House of Lords in the UK approves a bill to allow mitochondrial donation.

Featured White Papers

Reverse Phase Protein Arrays for Cell Signaling: Using the InnoScan 710-IR scanner improves sensitivity and dynamic range.

Infrared detection decreases nitrocellulose autofluorescence and improves RPPA assays signal‐to‐noise ratio over visible wavelength detection

Mar

05

Featured Webinar

Integrating Metabolomic and Proteomic Profiles for 'Less Impersonal' Medicine

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.

Main menu